Magazine

We are glad inform you about a recent publication to further support the usefulness of mucoprotection in the relief of symptoms and in the prevention of recurrences in uncomplicated UTIs

The trial "Xyloglucan + Gelose Combination versus Placebo as Adjuvant Therapy to First-Line Antimicrobials for Uncomplicated Urinary Tract Infection in Adults" has been published on Urologia Internationalis.

https://www.ncbi.nlm.nih.gov/pubmed/30889607

In the study, safety and efficacy of a Xyloglucan based medical device were investigated as adjuvant therapy to first-line antimicrobials for treatment of uncomplicated UTIs in adults.

New publication of a  retrospective, observational study of Gelatin tannate versus other antidiarrheal medication in children with acute Gastroenteritis.

“A clinical trial recently published assessed the efficacy, safety and tolerability of a xyloglucan-based nasal spray (Rhinosectan) in the treatment of rhinosinusitis, and concluded  that this medical device provided greater relief of symptoms than a physiological saline spray”. Allegrini A et al. A randomized controlled trial comparing a xyloglucan-based nasal spray with saline in adults with symptoms of rhinosinusitis. Current Medical Research and Opinion, 2017.  DOI: 0.1080/03007995.2017.1341402